UVA and UVB Phototherapy - Ray Reaction
- Erythema (sunburn) is the principal acute cutaneous reaction to UV radiation, dose-dependent.
- UVB Erythema:
- Onset: 2-6 hours post-exposure.
- Peak: 12-24 hours.
- Duration: 24-72 hours.
- Appearance: Bright red, tender; severe reactions may blister.
- Primarily prostaglandin-mediated.
- UVA Erythema (PUVA):
- Requires psoralen sensitization.
- Onset: More delayed, 24-36 hours.
- Peak: 48-72 hours (can be up to 96 hours).
- Duration: Longer, days to weeks.
- Appearance: Deeper, dusky erythema.
- Minimal Erythema Dose (MED): Lowest UV dose producing minimal, perceptible erythema with sharp borders at 24 hours (for UVB).
⭐ UVB-induced erythema typically peaks at 12-24 hours, while PUVA erythema (UVA + psoralen) peaks much later at 48-72 hours.
UVA and UVB Phototherapy - Spectrum Specifics
| Feature | NB-UVB | BB-UVB | PUVA (Psoralen + UVA) |
|---|---|---|---|
| Wavelength (nm) | 311-313 | 290-320 | 320-400 (UVA-I) |
| Psoralen | No | No | Yes (8-MOP, 5-MOP) |
| Efficacy | High | Moderate | Very High |
| Key Uses | Psoriasis, Vitiligo, Atopic Dermatitis | Psoriasis (less common) | Severe Psoriasis, Vitiligo, Mycosis Fungoides (MF), Eczema |
⭐ PUVA therapy (especially oral) carries the highest long-term risk of non-melanoma skin cancer (NMSC), particularly squamous cell carcinoma, among these phototherapy modalities.
- NB-UVB: Peak emission at 311 nm; optimal for psoriasis with fewer side effects than BB-UVB.
- BB-UVB: Contains more erythemogenic wavelengths (290-300 nm); largely replaced by NB-UVB.
- PUVA: Combines psoralen (oral/topical) with UVA light; potent for recalcitrant cases. 📌 Psoralen Used with UVA.
UVA and UVB Phototherapy - Disease Defeaters
Phototherapy uses specific wavelengths of UV light to treat various skin conditions.
| Condition | Preferred Phototherapy | Rationale/Notes |
|---|---|---|
| Psoriasis | NB-UVB (311-313 nm), PUVA | Antiproliferative, immunomodulatory. PUVA for severe/resistant cases. |
| Vitiligo | NB-UVB (311-313 nm), PUVA | Stimulates melanocyte function/migration. NB-UVB often 1st line. |
| Atopic Dermatitis | NB-UVB | Immunomodulatory, reduces S. aureus. PUVA for severe/recalcitrant. |
| Mycosis Fungoides (CTCL) | NB-UVB (early stage), PUVA | Induces apoptosis of malignant T-cells. PUVA for thicker plaques. |
| Polymorphous Light Eruption (PMLE) | NB-UVB, PUVA (prophylaxis) | Hardening effect, induces immune tolerance. Start weeks before sun exposure. |
| Uremic Pruritus | NB-UVB | Anti-inflammatory, alters nerve fiber function. |
| Lichen Planus | PUVA, NB-UVB | Immunomodulatory, antiproliferative. Oral LP may use UVA-1. |
UVA and UVB Phototherapy - Guarding Glow
- Mechanism: Induces T-cell apoptosis, alters cytokines, immunomodulation.
- NB-UVB (311-313 nm):
- Indications: Psoriasis, vitiligo, atopic dermatitis, Mycosis Fungoides (MF) (early), Polymorphic Light Eruption (PLE).
- Dosimetry: Minimal Erythema Dose (MED). Start 50-70% MED. Escalate 10-20% per session, 2-5x/week.
- Advantages: Effective, less erythemogenic than Broadband UVB (BB-UVB), pregnancy-safe.
- PUVA (Psoralen + UVA): Oral/topical psoralen + UVA (320-400 nm).
- Indications: Severe psoriasis, vitiligo, MF, Graft-versus-host disease (GVHD).
- Dosimetry: Minimal Phototoxic Dose (MPD).
- Side Effects: Acute: Nausea (oral), phototoxic erythema. Chronic: ↑ Squamous Cell Carcinoma (SCC), melanoma risk, photoaging. 📌 "P"soralen "P"otentiates "P"hotocarcinogenesis.
- General Side Effects (UVB/UVA): Acute: Erythema, pruritus, xerosis, blisters (if dose high). Chronic: Photoaging, Non-Melanoma Skin Cancer (NMSC).
- Contraindications: Absolute: Xeroderma Pigmentosum (XP), Systemic Lupus Erythematosus (SLE), Dermatomyositis (DM). Relative: Melanoma Hx, photosensitizing drugs.
⭐ NB-UVB (311-313 nm) is the most common phototherapy for psoriasis, offering an optimal balance of efficacy and safety, and is considered safe during pregnancy.
High‑Yield Points - ⚡ Biggest Takeaways
- NB-UVB (311 nm): Preferred for psoriasis, vitiligo; good efficacy/safety profile.
- UVB mechanism: Primarily immunosuppression and antiproliferative effects.
- PUVA (Psoralen + UVA): Forms DNA adducts; potent for psoriasis, mycosis fungoides; ↑ SCC risk.
- UVA1 (340-400 nm): Deepest penetration; for scleroderma, severe atopic dermatitis.
- Chronic risks: Photoaging, skin cancer. Eye protection crucial with PUVA.
- Dosing: MED (Minimal Erythema Dose) for UVB, MPD (Minimal Phototoxic Dose) for PUVA.
Unlock the full lesson and continue reading
Signup to continue reading this lesson and unlimited access questions, flashcards, AI notes, and more
